Literature DB >> 28837348

Homogeneous and Robust Polyproline Type I Helices from Peptoids with Nonaromatic α-Chiral Side Chains.

Olivier Roy1, Geoffrey Dumonteil1, Sophie Faure1, Laurent Jouffret1, Alexandre Kriznik2, Claude Taillefumier1.   

Abstract

Peptoids that are oligomers of N-substituted glycines represent a class of peptide mimics with great potential in areas ranging from medicinal chemistry to biomaterial science. Controlling the equilibria between the cis and trans conformations of their backbone amides is the major hurdle to overcome for the construction of discrete folded structures, particularly for the development of all-cis polyproline type I (PPI) helices, as tools for modulating biological functions. The prominent role of backbone to side chain electronic interactions (n → π*) and side chains bulkiness in promoting cis-amides was essentially investigated with peptoid aromatic side chains, among which the chiral 1-naphthylethyl (1npe) group yielded the best results. We have explored for the first time the possibility to achieve similar performances with a sterically hindered α-chiral aliphatic side chain. Herein, we report on the synthesis and detailed conformational analysis of a series of (S)-N-(1-tert-butylethyl)glycine (Ns1tbe) peptoid homo-oligomers. The X-ray crystal structure of an Ns1tbe pentamer revealed an all-cis PPI helix, and the CD curves of the Ns1tbe oligomers also resemble those of PPI peptide helices. Interestingly, the CD data reported here are the first for any conformationally homogeneous helical peptoids containing only α-chiral aliphatic side chains. Finally we also synthesized and analyzed two mixed oligomers composed of NtBu and Ns1tbe monomers. Strikingly, the solid state structure of the mixed oligomer Ac-(tBu)2-(s1tbe)4-(tBu)2-COOtBu, the longest to be solved for any linear peptoid, revealed a PPI helix of great regularity despite the presence of only 50% of chiral side chain in the sequence.

Entities:  

Year:  2017        PMID: 28837348     DOI: 10.1021/jacs.7b07475

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  Fluorinated Aromatic Monomers as Building Blocks To Control α-Peptoid Conformation and Structure.

Authors:  Diana Gimenez; Guangfeng Zhou; Matthew F D Hurley; Juan A Aguilar; Vincent A Voelz; Steven L Cobb
Journal:  J Am Chem Soc       Date:  2019-02-15       Impact factor: 15.419

Review 2.  Acyclic Twisted Amides.

Authors:  Guangrong Meng; Jin Zhang; Michal Szostak
Journal:  Chem Rev       Date:  2021-08-18       Impact factor: 72.087

3.  Stabilising Peptoid Helices Using Non-Chiral Fluoroalkyl Monomers.

Authors:  Diana Gimenez; Juan A Aguilar; Elizabeth H C Bromley; Steven L Cobb
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-27       Impact factor: 15.336

4.  Folding of unstructured peptoids and formation of hetero-bimetallic peptoid complexes upon side-chain-to-metal coordination.

Authors:  Maria Baskin; Hui Zhu; Zheng-Wang Qu; Jordan H Chill; Stefan Grimme; Galia Maayan
Journal:  Chem Sci       Date:  2018-10-17       Impact factor: 9.825

5.  Submonomer synthesis of peptoids containing trans-inducing N-imino- and N-alkylamino-glycines.

Authors:  Carolynn M Davern; Brandon D Lowe; Adam Rosfi; Elon A Ison; Caroline Proulx
Journal:  Chem Sci       Date:  2021-05-10       Impact factor: 9.825

6.  Peptoid Residues Make Diverse, Hyperstable Collagen Triple-Helices.

Authors:  Julian L Kessler; Grace Kang; Zhao Qin; Helen Kang; Frank G Whitby; Thomas E Cheatham; Christopher P Hill; Yang Li; S Michael Yu
Journal:  J Am Chem Soc       Date:  2021-07-13       Impact factor: 16.383

7.  Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer.

Authors:  Jeffrey A Schneider; Timothy W Craven; Amanda C Kasper; Chi Yun; Michael Haugbro; Erica M Briggs; Vladimir Svetlov; Evgeny Nudler; Holger Knaut; Richard Bonneau; Michael J Garabedian; Kent Kirshenbaum; Susan K Logan
Journal:  Nat Commun       Date:  2018-10-23       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.